
Find Reports
Select Report Type
Reimbursement Review
Displaying 1401 - 1422 of 1422
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1976 - 2000 of 2132
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Rasagiline mesylate | Reimbursement Review | Complete | SF0161-000 | ||||
Insulin detemir | Reimbursement Review | Complete | SR0172-000 | ||||
Desvenlafaxine succinate | Reimbursement Review | Complete | SR0159-000 | ||||
English-Language Restriction When Conducting Systematic Review-based Meta-analyses: Systematic Review of Published Studies | Health Technology Review | ||||||
Insulin detemir | Reimbursement Review | Withdrawn | SR0158-000 | ||||
Ustekinumab | Reimbursement Review | Complete | SR0156-000 | ||||
Solifenacin succinate | Reimbursement Review | Complete | SR0155-000 | ||||
Levodopa / carbidopa | Reimbursement Review | Complete | SR0154-000 | ||||
Alendronate sodium / cholecalciferol | Reimbursement Review | Complete | SR0153-000 | ||||
Teriparatide (rDNA origin) injection | Reimbursement Review | Complete | SR0152-000 | ||||
Teriparatide (rDNA origin) injection | Reimbursement Review | Withdrawn | SR0157-000 | ||||
Olmesartan medoxomil + hydrochlorothiazide | Reimbursement Review | Complete | SR0151-000 | ||||
Olmesartan medoxomil | Reimbursement Review | Complete | SR0150-000 | ||||
Tenofovir disoproxil fumarate | Reimbursement Review | Complete | SR0148-000 | ||||
Darifenacin hydrobromide | Reimbursement Review | Complete | SR0147-000 | ||||
Infliximab | Reimbursement Review | Complete | SR0146-000 | ||||
Insulin glulisine | Reimbursement Review | Complete | SR0144-000 | ||||
Abatacept | Reimbursement Review | Complete | SR0145-000 | ||||
Acamprosate calcium | Reimbursement Review | Complete | SF0143-000 | ||||
Sodium oxybate | Reimbursement Review | Complete | SR0141-000 | ||||
Ambrisentan | Reimbursement Review | Complete | SR0142-000 | ||||
Dabigatran etexilate | Reimbursement Review | Complete | SR0140-000 | ||||
Emtricitabine/tenofovir disoproxil fumarate | Reimbursement Review | Complete | SF0138-000 | ||||
Tenofovir disoproxil fumarate | Reimbursement Review | Complete | SF0139-000 | ||||
Methylnaltrexone bromide | Reimbursement Review | Complete | SR0135-000 |